Results showed a tendency toward increased salivary gland (+61.1%, p = 0.06) and liver uptake (+33.4%, p = 0.17) in 10 responders, defined as patients with a ≥ 30% decline in PSMA-positive tumor volume after 2 RLT cycles. Here, FOLH1 is linked to neoplasm.